GGrantIndex
← Search

Keck Biophysics Facility Shared Resource

$187,673P30FY2018CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications, trials & patents

Trial NCT07639528Trial NCT07594626Trial NCT07594548Trial NCT07290543Trial NCT07261657Trial NCT07178301Trial NCT07169617Trial NCT07050186Trial NCT07042919Trial NCT06959641Trial NCT06813898Trial NCT06723457Trial NCT06630416Trial NCT06571734Trial NCT06499870Trial NCT06410248Trial NCT06327477Trial NCT06247540Trial NCT06244004Trial NCT06242834Trial NCT06184750Trial NCT06164275Trial NCT06137651Trial NCT06062498Trial NCT06060587Trial NCT06022822Trial NCT05879250Trial NCT05852041Trial NCT05802186Trial NCT05744739Trial NCT05733000Trial NCT05620771Trial NCT05576896Trial NCT05545150Trial NCT05453799Trial NCT05419011Trial NCT05411107Trial NCT05236036Trial NCT05202782Trial NCT05093387Trial NCT04931017Trial NCT04910425Trial NCT04795869Trial NCT04767984Trial NCT04753216Trial NCT04576104Trial NCT04550481Trial NCT04250051Trial NCT04227028Trial NCT04200443Trial NCT04049227Trial NCT04047706Trial NCT04033432Trial NCT04009044Trial NCT03854474Trial NCT03812562Trial NCT03742258Trial NCT03723915Trial NCT03704714Trial NCT03513484Trial NCT03317405Trial NCT03278925Trial NCT03226249Trial NCT03213041Trial NCT03146650Trial NCT03077828Trial NCT03070002Trial NCT03061188Trial NCT03048500Trial NCT03044730Trial NCT03036930Trial NCT03020017Trial NCT02993159Trial NCT02968810Trial NCT02965703Trial NCT02901899Trial NCT02892734Trial NCT02871323Trial NCT02861040Trial NCT02847559Trial NCT02837029Trial NCT02819804Trial NCT02808143Trial NCT02805868Trial NCT02794883Trial NCT02774681Trial NCT02743364Trial NCT02720484Trial NCT02694809Trial NCT02536794Trial NCT02530619Trial NCT02530502Trial NCT02530125Trial NCT02481310Trial NCT02365480Trial NCT02357810Trial NCT02314156Trial NCT02242097Trial NCT02237183Trial NCT02232516

Abstract

ABSTRACT ? KECK BIOPHYSICS FACILITY The Keck Biophysics Facility is a shared resource for biophysical research, providing Northwestern researchers with state-of-the-art equipment, specialized services, and technical expertise for integrated analyses of macromolecular structure, interactions, and function. The Keck Facility plays a central role in enabling molecular cancer research in the Lurie Cancer Center (LCC) by providing a broad range of high-end instrumentation that is beyond the reach of individual laboratories with respect to both cost and operator expertise. We offer advanced capabilities for characterization of molecular interactions, comprehensive structure and activity characterization of proteins and other biological and synthetic macromolecules, characterization of solutions of drugs, peptides, biomolecules and nanoparticles, and sophisticated capabilities for imaging gels, blots and microplates. Further, the Keck Facility is regularly evaluating and implementing new technologies in order to meet the evolving needs of LCC researchers. In the past five years, several new instruments and services intended primarily for early stage translational research studies were introduced. These include bio-layer interferometry (BLI) and multichannel surface plasmon resonance (SPR), both critical to the Center?s validation and translation of small molecule and macromolecular therapeutic agents, as well as nanoparticle tracking analysis (NTA), which is used for characterization of exosomes and therapeutic nanoparticles. The facility also continues to invest in personnel training and professional development, in modernizing its digital infrastructure, and in fostering interdisciplinary collaborations and partnerships with other LCC Cores. The core facility is extensively utilized by LCC members, with 52 LCC principal investigators using the facility over the last year. Data obtained in the facility were included in over 100 peer-reviewed publications from LCC researchers, since the last CCSG renewal submission. As such, the Keck Biophysics Facility remains a critical resource for cancer research.

View original record on NIH RePORTER →